Jerome D. Jabbour
2016
In 2016, Jerome D. Jabbour earned a total compensation of $481.3K as President at Matinas BioPharma Holdings, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Option Awards | $108,500 |
| Salary | $282,804 |
| Total | $481,304 |
Jabbour received $282.8K in salary, accounting for 59% of the total pay in 2016.
Jabbour also received $90K in bonus and $108.5K in option awards.
Rankings
In 2016, Jerome D. Jabbour's compensation ranked 11,323rd out of 14,075 executives tracked by ExecPay. In other words, Jabbour earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,323 out of 14,075 | 20th |
Division Manufacturing | 4,407 out of 5,486 | 20th |
Major group Chemicals And Allied Products | 1,581 out of 1,900 | 17th |
Industry group Drugs | 1,278 out of 1,543 | 17th |
Industry Pharmaceutical Preparations | 992 out of 1,173 | 15th |
Source: SEC filing on September 14, 2017.
Jabbour's colleagues
We found two more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2016.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019